Mobile Technology for Blood Pressure Management
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mobile technology intervention
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- 18 years or older with an established diagnosis of essential hypertension
Exclusion Criteria:
- Patients on more than 2 antihypertensives at time of enrollment
- Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
- Renal artery stenosis
- Primary hyperaldosteronism
- Cushing syndrome
- Coarctation of the aorta
- Drug-induced hypertension
- Pheochromocytoma
- Obstructive sleep apnea
- Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
- Hospitalization for unstable angina or myocardial infarction in the preceding 6 months
- Prior diagnosis of heart failure or cardiomyopathy
- Stroke or transient ischemic attack within prior 6 months
- Prior organ transplantation
- Failure to obtain informed consent
- Pregnant or currently trying to become pregnant
- Patients who are enrolled in other research studies
Sites / Locations
- Stanford University
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Single-arm: Blood pressure intervention
Arm Description
Participants will use a mobile technology system comprising of a remote home blood pressure monitoring cuff and a mobile application integrated with a clinician-facing component to view and manage remote blood pressures. Participants will use this for 12 weeks, with assessment of blood pressure outcomes and anonymous surveys regarding the technology at 12 weeks.
Outcomes
Primary Outcome Measures
Blood pressure
Systolic and diastolic blood pressures for each participant measured by home blood pressure monitoring
Participant survey
A survey regarding usability and feedback about the intervention completed by participants
Secondary Outcome Measures
Full Information
NCT ID
NCT04841317
First Posted
April 7, 2021
Last Updated
August 27, 2023
Sponsor
Stanford University
Collaborators
American Heart Association
1. Study Identification
Unique Protocol Identification Number
NCT04841317
Brief Title
Mobile Technology for Blood Pressure Management
Official Title
Implementing a Mobile Technology-Based System for Physician-Directed Remote Management of Hypertension: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
March 31, 2021 (Actual)
Primary Completion Date
December 31, 2022 (Actual)
Study Completion Date
December 31, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
American Heart Association
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
31 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Single-arm: Blood pressure intervention
Arm Type
Experimental
Arm Description
Participants will use a mobile technology system comprising of a remote home blood pressure monitoring cuff and a mobile application integrated with a clinician-facing component to view and manage remote blood pressures. Participants will use this for 12 weeks, with assessment of blood pressure outcomes and anonymous surveys regarding the technology at 12 weeks.
Intervention Type
Combination Product
Intervention Name(s)
Mobile technology intervention
Intervention Description
Home blood pressure cuff used by patients twice a week, with blood pressures transmitted to providers remotely
Primary Outcome Measure Information:
Title
Blood pressure
Description
Systolic and diastolic blood pressures for each participant measured by home blood pressure monitoring
Time Frame
12 weeks
Title
Participant survey
Description
A survey regarding usability and feedback about the intervention completed by participants
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18 years or older with an established diagnosis of essential hypertension
Exclusion Criteria:
Patients on more than 2 antihypertensives at time of enrollment
Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
Renal artery stenosis
Primary hyperaldosteronism
Cushing syndrome
Coarctation of the aorta
Drug-induced hypertension
Pheochromocytoma
Obstructive sleep apnea
Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
Hospitalization for unstable angina or myocardial infarction in the preceding 6 months
Prior diagnosis of heart failure or cardiomyopathy
Stroke or transient ischemic attack within prior 6 months
Prior organ transplantation
Failure to obtain informed consent
Pregnant or currently trying to become pregnant
Patients who are enrolled in other research studies
Facility Information:
Facility Name
Stanford University
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29133356
Citation
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13. No abstract available. Erratum In: Hypertension. 2018 Jun;71(6):e140-e144.
Results Reference
background
PubMed Identifier
12493255
Citation
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13. doi: 10.1016/s0140-6736(02)11911-8. Erratum In: Lancet. 2003 Mar 22;361(9362):1060.
Results Reference
background
PubMed Identifier
19454737
Citation
Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009 May 19;338:b1665. doi: 10.1136/bmj.b1665.
Results Reference
background
PubMed Identifier
23989679
Citation
Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013 Aug 21;310(7):699-705. doi: 10.1001/jama.2013.108769.
Results Reference
background
PubMed Identifier
22615116
Citation
Logan AG, Irvine MJ, McIsaac WJ, Tisler A, Rossos PG, Easty A, Feig DS, Cafazzo JA. Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics. Hypertension. 2012 Jul;60(1):51-7. doi: 10.1161/HYPERTENSIONAHA.111.188409. Epub 2012 May 21.
Results Reference
background
PubMed Identifier
17765133
Citation
Logan AG, McIsaac WJ, Tisler A, Irvine MJ, Saunders A, Dunai A, Rizo CA, Feig DS, Hamill M, Trudel M, Cafazzo JA. Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients. Am J Hypertens. 2007 Sep;20(9):942-8. doi: 10.1016/j.amjhyper.2007.03.020.
Results Reference
background
PubMed Identifier
31732293
Citation
Casey DE Jr, Thomas RJ, Bhalla V, Commodore-Mensah Y, Heidenreich PA, Kolte D, Muntner P, Smith SC Jr, Spertus JA, Windle JR, Wozniak GD, Ziaeian B. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2019 Nov 26;74(21):2661-2706. doi: 10.1016/j.jacc.2019.10.001. No abstract available.
Results Reference
background
Learn more about this trial
Mobile Technology for Blood Pressure Management
We'll reach out to this number within 24 hrs